Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC)

NCT01435460 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Conjunctivitis

Interventions

DRUG: Loteprednol etabonate 0.2%
DRUG: Olopatadine 0.1%

Sponsor

Bausch & Lomb Incorporated